The FDA’s Black-Box Reversal on Hormone Therapy: What the 2026 Label Changes Mean for Primary Care
By Dr. Anush S. Pillai, DO, FAAFP | Reviewed by CME Travel Academy Faculty 9 min read · Reviewed August 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference For more than twenty years, the boxed warning on menopausal hormone therapy has shaped